Article
Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients.
Journal of neuro-oncology - 1 May 2015
Mur Pilar, Rodríguez de Lope Ángel, Díaz-Crespo Francisco Javier, Hernández-Iglesias Teresa, Ribalta Teresa, Fiaño Concepción, García Juan Fernando, Rey Juan Antonio, Mollejo Manuela, Meléndez Bárbara
Abstract excerpt
Clinical and molecular prognostic factors in gliomas include age, IDH mutation, the glioma CpG island methylator phenotype (G-CIMP+) and promoter methylation of the O(6)-methylguanine DNA-methyltransferase (MGMT) gene. Among these markers, a predictive value was reported in glioblastomas (GBM) for MGMT promoter methylation, in particular in elderly GBM patients. In this study, methylation data from 46 glioma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
